China’s First 2024 Biotech Acquisition by DCTY
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
- Latest
- Trending
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
Maccabi Healthcare adopts Cynerio's platform to protect IoT systems, ensuring data security and service continuity.
McLaren Health Care hit by cyberattack affecting 13 hospitals in Michigan, causing disruptions but no confirmed data breaches.
McLaren Health Care faces a major cyber attack, disrupting phone and computer systems but maintaining patient care. Experts are investigating.
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Inspire Medical Systems reports a 30% revenue increase in Q2 2024, with net income of $9.8 million, and raises full-year ...
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
A hospice center in Yuma introduces VR to offer mobility-limited patients therapeutic benefits and mental relief.
McLaren Health Care is experiencing IT and phone system outages, impacting patient services. The health system is working to resolve ...
DaVita increases 2024 profit outlook due to high demand for kidney dialysis services, boosting shares by 3% in aftermarket trade.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.